发明名称 |
PARENTERAL FORMULATIONS OF RASAGILINE |
摘要 |
This application provides a method of preferentially inhibiting monoamine oxidase A (MAOA) in the brain of a subject relative to in the intestine of the subject comprising parenterally administering to the subject a controlled release formulation comprising a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt thereof. |
申请公布号 |
US2014051767(A1) |
申请公布日期 |
2014.02.20 |
申请号 |
US201313969295 |
申请日期 |
2013.08.16 |
申请人 |
FITZER-ATTAS CHERYL;ELIAZ ROM E.;BLAUGRUND ERAN;GROSS AVIVA;MAYK ADI;TEVA PHARMACEUTICAL INDUSTRIES, LTD. |
发明人 |
FITZER-ATTAS CHERYL;ELIAZ ROM E.;BLAUGRUND ERAN;GROSS AVIVA;MAYK ADI |
分类号 |
A61K31/135;A61K9/00 |
主分类号 |
A61K31/135 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|